Search results
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 4 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
Dear Doctor: Man’s overactive bladder has him up 4, 5 times a night
OregonLive.com· 1 day agoROACH: I’m a 87-year-old male who was diagnosed with an overactive bladder. Nothing has worked; I’m up four to five times a night, which leaves me very tired the next day. ANSWER: Before making ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...
Benzinga· 15 hours agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech ALVO, today announced the availability of SIMLANDI (adalimumab-ryvk) injection ...
“A day of shame” for the British state
The Economist· 20 hours agoDerek Martindale was 23 in 1985, when he was told that he had HIV and 12 months to live. After Richard died in 1990 Mr Martindale asked to see his...
Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array
Zacks via Yahoo Finance· 5 days agoThermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 9 hours agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung
A prognostic neural epigenetic signature in high-grade glioma - Nature Medicine
Nature· 4 days agoA neural epigenetic signature detectable via plasma analyses is prognostic in patients with glioblastoma, resembling an oligodendrocyte-progenitor- and neuronal-progenitor-cell-like state and showing increased neuro-to-glioma synapse formation.
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoM2SR also has shown activity as a vaccine vector for other respiratory...Flu combination. With our proprietary HSC technology and artificial intelligence platform that efficiently analyzes more ...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 5 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for...
Morningstar· 7 days agoTOKYO and CAMBRIDGE, Mass., May 14, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
